Please login to the form below

Not currently logged in
Email:
Password:

Venus secures EU patent for Achnil

Venus Remedies has been granted a patent by the European Patent Office for its research drug Achnil, a once-daily painkiller injection

Venus Remedies has been granted a patent by the European Patent Office (EPO) for its research drug Achnil, a once-daily painkiller injection.

The patent will run until 2025 in the member countries of EPO, reinforcing the market position of Venus Remedies in the major economies such as France, Germany, Italy, Spain, Sweden, and Switzerland and UK.

Dr Manu Chaudhry, joint managing director, said: "This novel formulation based on NDDS (novel drug delivery system) technology is going to fill the gap of long standing demand for better pain management therapy. Especially for aged population, it is not only going to reduce the number of pricks but will also drastically reduce the side effects associated with the use of NSAIDs [non-steroidal anti-inflammatory drugs]."

The development of Achnil took more than five years and has completed phase-III clinical trials successfully.

The company said it has plans to commercialise Achnil formulation in the European market through out-licensing of exclusive marketing rights to a pharma major.

24th May 2011

Share

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Page & Page

For those who can imagine better, Page & Page is home to meaningful encounters of a marketing, communication and creative kind:...

Latest intelligence

Planning your clinical trial? Why you need to engage patients sooner
It’s highly likely that clinical studies are deterring patients based on decisions made in the early stages, such as during planning and design....
Patient-centricity in improving patient recruitment advertising
This blog looks into the importance of concepts and patient centricity in patient recruitment....
AI and life sciences
AI: the smart money is on the smart thinking
Looking at the three key areas where AI is being applied: drug discovery, clinical decision-making and clinical trials...

Infographics